Status:

COMPLETED

Corellation of Mutations, TILs and Age in Breast Cancer

Lead Sponsor:

Hellenic Cooperative Oncology Group

Conditions:

Breast Cancer

Eligibility:

FEMALE

18+ years

Brief Summary

Age may pertain to different tumor genotype characteristics which may interfere with treatment efficacy and prognosis. The investigators investigated the distribution and prognostic effect of mutation...

Eligibility Criteria

Inclusion

  • women with early breast cancer \<35 years old or \>65 years old

Exclusion

  • NA

Key Trial Info

Start Date :

September 3 1997

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

345 Patients enrolled

Trial Details

Trial ID

NCT04033965

Start Date

September 3 1997

End Date

October 1 2010

Last Update

July 26 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Corellation of Mutations, TILs and Age in Breast Cancer | DecenTrialz